Literature DB >> 8508951

A revised strategy for cloning antibody gene fragments in bacteria.

B Posner1, I Lee, T Itoh, J Pyati, R Graff, G B Thorton, R La Polla, S J Benkovic.   

Abstract

The ability to clone and overexpress genes encoding mouse Fab (antigen-binding fragment) proteins in bacteria led to the development of a methodology which has the potential to replace traditional hybridoma technology [Huse et al., Science 246 (1989) 1275-1281]; however, several observations have suggested that clones with desirable chemical properties may be missed in immunoscreens of large combinatorial libraries due to low levels of functional Ab protein. To increase the efficiency of cloning and characterization of Ab gene fragments, we have reconsidered several features of the original cloning vehicles. These studies show that at the present time a unique expression system cannot adequately accommodate the requirements of plaque-lift immunoassays for clonal selection and biochemical assays for further characterization in vitro. A monocistronic arrangement of heavy- and light-chain-encoding genes using two lacP promoters produces sufficient amounts of functional Ab protein for clonal selection from phage lambda libraries and minimizes interference with the lytic cycle of recombinant vectors. In liquid culture, a strong coliphage promoter and a relatively abundant RNA polymerase can be used to produce quantities of Ab protein sufficient for further characterization in vitro. A rapid purification protocol obviates the need for fusing heavy-chain protein to a decapeptide sequence, an affinity-tail sequence which slows the folding and assembly of the Ig heterodimer. These results have been used to formulate a new strategy for cloning and characterization of Ab gene fragments in bacteria.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8508951     DOI: 10.1016/0378-1119(93)90161-u

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  Combinatorial protein engineering by incremental truncation.

Authors:  M Ostermeier; A E Nixon; J H Shim; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 2.  In vivo versus in vitro screening or selection for catalytic activity in enzymes and abzymes.

Authors:  J Fastrez
Journal:  Mol Biotechnol       Date:  1997-02       Impact factor: 2.695

Review 3.  Dissection of an antibody-catalyzed reaction.

Authors:  J D Stewart; J F Krebs; G Siuzdak; A J Berdis; D B Smithrud; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

4.  CellectSeq: In silico discovery of antibodies targeting integral membrane proteins combining in situ selections and next-generation sequencing.

Authors:  Abdellali Kelil; Eugenio Gallo; Sunandan Banerjee; Jarrett J Adams; Sachdev S Sidhu
Journal:  Commun Biol       Date:  2021-05-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.